Skip to main content
. 2021 Mar 22;11:633827. doi: 10.3389/fonc.2021.633827

Figure 4.

Figure 4

Schematic representation of nano-targeting of glioma-associated TAMCs. (CTL, cytotoxic T lymphocyte; Teff, effector T cell; PD-1, programmed cell death protein 1; IFNGR, IFN gamma receptor) (48).